The Untapped Potential of Comprehensive Genomic Profiling

The introduction of biomarkers and genomically matched therapies has revolutionised our approach to cancer treatment. In addition, focus on the molecular aspects of tumours, combined with advances in high computing power and the rise of artificial intelligence (AI), will continue to drive several paradigm shifts in cancer care. Soon, it may be the tumour’s molecular profile, in addition to its origin, that defines the cancer’s categorisation and associated optimal treatments. Comprehensive Genomic Profiling (CGP) – a single test for all cancer types – is highly effective for this purpose. Recent ESMO guidelines also recommend the use of broad molecular diagnostics…

Keep reading